To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Arms Length Body Publication (Published)
NICE

Aug. 19 2025

Source Page: Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinoma
Publication Type: Summary PDF
Document: Download guidance (PDF) (webpage)
Arms Length Body Publication (Published)
NICE

Aug. 19 2025

Source Page: Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinoma
Publication Type: Resource impact
Document: Resource impact template (Excel 2.3 MB) (webpage)
Arms Length Body Publication (Published)
NICE

Aug. 19 2025

Source Page: Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinoma
Publication Type: Summary PDF
Document: Download (PDF) (webpage)
Arms Length Body Publication (Published)
NICE

Aug. 19 2025

Source Page: Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinoma
Publication Type: Supporting evidence
Document: Draft guidance consultation committee papers (PDF 7.35 MB) (webpage)
Arms Length Body Publication (Published)
NICE

Aug. 19 2025

Source Page: Durvalumab with tremelimumab for untreated advanced or unresectable hepatocellular carcinoma
Publication Type: Supporting evidence
Document: Final draft guidance committee papers (PDF 1.06 MB) (webpage)
Arms Length Body Publication (Policy or strategy)
NHS England

Aug. 19 2025

Source Page: Bortezomib for the treatment in acute immune thrombotic thrombocytopenic purpura (TTP) and elective therapy to prevent immune TTP relapse in patients who are refractory or intolerant to rituximab (all ages)
Document: Clinical commissioning policy: bortezomib for the treatment in acute immune thrombotic thrombocytopenic purpura (TTP) and elective therapy to prevent immune TTP relapse in patients who are refractory or intolerant to rituximab (all ages) (PDF)
Arms Length Body Publication (Guidance)
NHS England

Aug. 19 2025

Source Page: Elective care capital incentive scheme: returning to the RTT standard
Document: Elective care capital incentive scheme: returning to the RTT standard (webpage)
Arms Length Body Publication (Regulatory)
NHS England

Aug. 18 2025

Source Page: NHS Federated Data Platform data protection impact assessment – National Data Integration Tenant minimum viable product
Document: NHS Federated Data Platform data protection impact assessment – National Data Integration Tenant minimum viable product (webpage)
Arms Length Body Publication (Published)
NICE

Aug. 15 2025

Source Page: Digital front door technologies to gather service user information for NHS Talking Therapies for anxiety and depression assessments: early value assessment
Publication Type: Expected publication
Document: Committee papers (PDF 2.69 MB) (webpage)
Arms Length Body Publication (Case study)
NHS England

Aug. 15 2025

Source Page: Hepatitis B: from diagnosis to understanding, advocacy and challenging stigma
Document: Hepatitis B: from diagnosis to understanding, advocacy and challenging stigma (webpage)